Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

9.440 +0.050 (+0.53%)
Streaming Delayed Price Updated: 2:14 PM EST, Jan 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces Issuance of Additional US Patent Related to the NeXT Personal™ Platform
From Personalis, Inc.
Via Business Wire
News headline image
Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022
From Personalis, Inc.
Via Business Wire
News headline image
Personalis: Q4 Earnings Insights ↗
Personalis (NASDAQ:PSNL) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a... 
Via Benzinga
News headline image
Personalis to Present at the 21st Annual Needham Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
News headline image
Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of Directors
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Reports Fourth Quarter and Full Year 2021 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Present at the Cowen 42nd Annual Health Care Conference
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces Collaboration with UC San Diego Moores Cancer Center for Clinical Genomic Testing and Research into Composite Biomarkers and Minimal Residual Disease Detection
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Announce Fourth Quarter and Full-Year Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Personalis, Inc.
Via Business Wire
News headline image
56 Biggest Movers From Friday ↗
Gainers Hour Loop, Inc. (NASDAQ: HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share. China HGS Real Estate Inc. (NASDAQ: HGSH) shares... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by... 
Via Benzinga
News headline image
33 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 35.9% to $4.6899 after the company announced an integration with Amazon Ads' demand-side platform. Absci... 
Via Benzinga
News headline image
Personalis Reports Preliminary Fourth Quarter and Full Year 2021 Revenue
From Personalis, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers SomaLogic (NASDAQ:SLGC) shares mo... 
Via Benzinga
News headline image
Personalis to Participate in the 24th Annual Needham Virtual Growth Conference
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Named to Inc.'s 2021 Best-Led Companies List
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Present New Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
From Personalis, Inc.
Via Business Wire
News headline image
Personalis's Return On Capital Employed Insights ↗
Benzinga Pro data, Personalis (NASDAQ:PSNL) reported Q3 sales of $22.26 million. Earnings fell to a loss of $17.69 million, resulting in a 18.36% decrease from last quarter.... 
Via Benzinga
News headline image
Personalis Reports Third Quarter 2021 Financial Results
From Personalis, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2021 ↗
Upgrades Benchmark upgraded the previous rating for Devon Energy Corp (NYSE: 
Via Benzinga
News headline image
Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces Issuance of US Patents Related to the Exome-Wide NeXT Liquid Biopsy Platform
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Publishes New Data Demonstrating Performance and Utility of SHERPA for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Announce Third Quarter Financial Results on November 4, 2021
From Personalis, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.